Cargando…
Genetic Mechanisms of Asthma and the Implications for Drug Repositioning
Asthma is a chronic disease that is caused by airway inflammation. The main features of asthma are airway hyperresponsiveness (AHR) and reversible airway obstruction. The disease is mainly managed using drug therapy. The current asthma drug treatments are divided into two categories, namely, anti-in...
Autores principales: | Huo, Yue, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977177/ https://www.ncbi.nlm.nih.gov/pubmed/29751569 http://dx.doi.org/10.3390/genes9050237 |
Ejemplares similares
-
The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017) -
Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2020) -
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022) -
Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012) -
Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)